NYSE: CELG - Celgene

Yield per half year: 0%
Sector: Healthcare

Celgene

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
13.33 57.99 -77.01% 31.56 -57.76%
P/S 4.61 4.07 13.25%
P/BV 6.37 9.41 -32.33%
P/FCF 0 46.88 -100%
Ev/Ebitda 10.62 17.44 -39.11%
Ev/S 0 4.38 -100%
Ev/FCF 0 55.55 -100%
E/P 0 0.2163 -100%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
0 20.21 -100% 35.73 -100%
ROE 69.39 -80.94 -185.73%
ROA 15.56 6.66 133.5%
ROIC 22.6 15.68 44.16%
ROS 34.62 10.5 229.7%
ROCE 0 19.22 -100%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0 2.86 -100% 2.1 -100%
Nеt Debt/Ebitda 0 3.72 -100%
Debt/Ratio 0 0.2638 -100%
Debt/Equity 0 4.81 -100%
Debt/Net Income 0 6.51 -100%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.24 -100% 0 0%
Number of years of dividend growth 0 0.9365 -100%
DSI 0 0.7161 -100%
Average dividend growth 0 -0.182 -100%
Average percentage for 5 years 0 1.26 -100%
Average percentage for payments 0 77.6 -100%
Difference from average difference in sector -1.24
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
9/10
83.37 446.18 -81.31%
Growth impulse Ebitda 5 years 115.77 615.43 -81.19%
Growth impulse Net Income 5 years 267.5 553.09 -51.64%
Growth impulse FCF 5 years 84 330.41 -74.58%
Growth impulse EPS 5 years 314.95 549.99 -42.74%
IP Score
6.33/10

Similar companies

UnitedHealth Group

AbbVie

Bristol-Myers

Johnson & Johnson